International audience; Background 5-HT3 antagonists have been shown to be effective in relieving symptoms of IBS-D. Using a recently validated MRI method we have demonstrated reduced fasting small bowel water content (SBWC) in IBS-D associated with accelerated small bo... View more
1. Bulbring E, Crema A. The action of 5-hydroxytriptamine, 5-hydroxytriptophan and reserpine on intestinal peristalsis in anaesthetized guinea pigs. J Physiol (Lond) 1959; 146: 29-53.
2. FoxxOrenstein AE, Kuemmerle JF, Grider JR. Distinct 5-HT receptors mediate the peristaltic reflex induced by mucosal stimuli in human and guinea pig intestine. Gastroenterology 1996; 111: 1281- 1290.
3. Gershon MD. Review article: serotonin receptors and transporters - roles in normal and abnormal gastrointestinal motility. Aliment Pharmacol Ther 2004; 20: 3-14.
4. Spiller R. Role Fofmotility in chronic diarrhoea. Neurogastroenterol Motil 2006; 18: 1045-1055.
5. Grider JR. Regulatoionof excitatory neural input to longitudinal intestinal muscle by myenteric interneurons. Am J Physiol 1998; 275: G973-G978.
6. Cremonini F, Delgado-rAros S, Camilleri M. Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials. Neurogastroenterol Motil 2003; 15: 79-86.
7. Prior A, Read NW. ReductiPonof rectal sensitivity and postprandial motility by granisetron, a 5- HT(3) receptor antagonist, in patients with irritable bowel syndrome. Aliment Pharmacol Ther 1993; 7: 175-180. e
8. Vonderohe MR, Camilleri M, Kvols eLK. A 5-HT(3) antagonist corrects the postprandial colonic hypertonic response in carcinoid diarrhea. Gastroenterology 1994; 106: 1184-1189.
9. Gore S, Gilmore IT, Haigh CG, et al. Colornic transit in man is slowed by Ondansetron (GR38032F), a selective 5-hydroxytryptamine receptor (type 3) antagonist. Aliment Pharmacol Ther 1990; 4: 139-144.
10. Talley NJ, Phillips SF, Haddad A, et al. GRR-38032F (Ondansetron), a selective 5-HT3 receptor antagonist, slows colonic transit in healthy man. Dig Dis Sci 1990; 35: 477-480.